Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

Specimen Handling 321 Magnetic Resonance Spectroscopy 276 pembrolizumab 265 Carboplatin 190 Cyclophosphamide 184 Biopsy 179 Cisplatin 163 Paclitaxel 137 Gemcitabine 137 Bevacizumab 124 fludarabine 119 Nivolumab 117 Radiotherapy 114 Oxaliplatin 92 Docetaxel 90 venetoclax 89 Fluorouracil 88 Capecitabine 88 Dexamethasone 86 Pemetrexed 75 Drug Therapy 73 Rituximab 72 Leucovorin 71 durvalumab 70 Blood Specimen Collection 69 Radiosurgery 68 atezolizumab 67 Standard of Care 67 Doxorubicin 65 Radiation 63

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × oprelvekin × 90 days × Clear all

NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting

Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡